Digital & Innovation
$19 million investment in Artificial Intelligence medical research
The Morrison Government is investing $19 million in transformative medical research projects using game-changing applied artificial intelligence (AI) technologies, to improve the ways we prevent, diagnose and treat a wide range of health conditions.
The Government is providing more than $8 million for two projects that will use AI to improve mental health treatments for Australians.
The University of Sydney will receive more than $3 million to improve youth mental health care through the development of new tools to guide clinical decisions about the appropriate interventions and treatments for individuals presenting for care.
This project will use AI to test and quantify the impacts of youth mental health interventions and as a result support the development of an ethical clinical decision-support tool that identifies how to target assessment and interventions to optimise outcomes for individuals presenting for mental health care.
The University of New South Wales will receive almost $5 million to use AI to understand and optimise the treatments for stress, anxiety and depression.
AI will be used to understand which interventions, or components of therapies provide the vital, active ingredients, and why they are more effective for some patients and not others.
The aim of this project is to use AI to shorten the trial period where some people are provided with non‑optimal treatments for their conditions and thus improving their health, social and economic wellbeing.
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More